Swiss Pharma at Risk of US Trade Investigation, Industry Body Says - Regional Media News

Swiss pharma at risk of US trade investigation, industry body says - Regional Media News

ZURICH, June 26 (Reuters) - The United States could open a trade investigation into Switzerland's pharmaceutical industry similar to the one initiated last week against Germany, the head of Swiss industry body Interpharma said on Friday. Washington has launched so-called Section 301 investigations into suspected unfair trade practices against dozens of countries. It initiated the probe against Germany after Berlin unveiled plans in April for a w…

Swiss pharma faces potential US trade investigation as Washington turns up pressure on drug pricing

The potential US trade investigation could disrupt Swiss pharma exports, impacting global drug pricing dynamics and international trade relations. The post Swiss pharma faces potential US trade investigation as Washington turns up pressure on drug pricing appeared first on Crypto Briefing.